Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study

Carbapenem-resistant Acinetobacter baumannii (CRAB) is one of the most commonly found nosocomial infections in critically ill patients. However, the appropriate treatment period for a specific group of critically ill patients with CRAB infection is currently being debated. Therefore, our study aimed...

Full description

Saved in:
Bibliographic Details
Published in:Journal of infection and public health 2023-08, Vol.16 (8), p.1249-1255
Main Authors: Katip, Wasan, Rayanakorn, Ajaree, Oberdorfer, Peninnah, Taruangsri, Puntapong, Nampuan, Teerapong
Format: Article
Language:English
Subjects:
Acinetobacter baumannii - physiology
Acinetobacter Infections - microbiology
Anti-Bacterial Agents
Carbapenems - therapeutic use
Colistin
Colistin - therapeutic use
CRAB infection
Critical Illness
Critically ill patients
Duration of treatment
Humans
Propensity Score
Propensity score analysis
Retrospective Studies
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Carbapenem-resistant Acinetobacter baumannii (CRAB) is one of the most commonly found nosocomial infections in critically ill patients. However, the appropriate treatment period for a specific group of critically ill patients with CRAB infection is currently being debated. Therefore, our study aimed to evaluate the optimal courses of therapy for critically ill patients with CRAB infection by comparing the outcomes of colistin therapy of short duration (
ISSN:1876-0341
1876-035X
DOI:10.1016/j.jiph.2023.05.024